Financial Results for March 31, 2012
Panacea Biotec Ltd has informed BSE about the Financial Results for the period ended March 31, 2012.19-05-2012
19-05-2012
Board to consider Dividend
Panacea Biotec Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 18, 2012, inter alia, to consider and approve the Audited Financial Results for the Financial Year 2010-11 and also to consider the matter pertaining to recommendation / passing over of dividend.26-04-2012
Panacea Biotec inaugurates state of the art Oncology Production Unit
Panacea Biotec Ltd has informed BSE regarding a Press Release dated March 28, 2012, titled "Panacea Biotec inaugurates state of the art Oncology Production Unit".Press Release:"Panacea Biotec, India's leading health care management Company has inaugurated its new state-of-the-art Oncology facility at Baddi, Himachal Pradesh to meet the growing demand of anti-cancer products in the country." (For more details kindly refer Corporate Announcements on www.bseindia.com).28-03-2012
WHO delist Company's OPV from its prequalified vaccines list
Panacea Biotec Ltd has informed BSE regarding "WHO delist Company's OPV from its prequalified vaccines list".Announcement:"After a site audit of the Oral Polio Vaccine (OPV) manufacturing facility at New Delhi, the Company had undertaken several measures regarding refurbishment of the facility and strengthening of QMS from September to December, 2011. WHO team visited manufacturing facility, Okhla, New Delhi from 3rd January to 1st...05-03-2012
Panacea Biotec celebrates 63rd Indian Republic day with launch of "POLPROTEC" in Nigeria
Panacea Biotec Ltd has informed BSE regarding a Press Release dated February 21, 2012, titled "Panacea Biotec celebrates 63rd Indian Republic day with launch of "POLPROTEC" in Nigeria"."Panacea Biotec, India's leading vaccine manufacturer celebrated the 63rd Indian Republic Day in a unique manner by launching POLPROTEC (an enhanced potency, inactivated poliovirus vaccine) in Nigeria in collaboration with Emzor Pharma. Nigeria....21-02-2012
Financial Results & Limited Review for Dec 31, 2011
Panacea Biotec Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended December 31, 2011.10-02-2012
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Panacea Biotec Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:23-11-2011
Limited Review for the quarter ended Sep 30, 2011
Panacea Biotec Ltd has informed BSE that the auditor's have conducted the limited review of the unaudited financial results for the quarter ended September 30, 2011.18-11-2011
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Serum Institute of India Ltd has submitted the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE.31-10-2011